NEW YORK, March 27 - Micromass MS Technologies has sold its inorganic mass-spectrometry business to a newly formed British company created for the sole purpose of manufacturing and selling the instruments, the company said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.
Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.
NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.
In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.